Pfizer to launch an innovative anti-fungal drug.

Published: 2005-09-06 06:59:00

Updated: 2005-09-06 06:59:00

Pfizer Korea has launched an innovative anti-fungal drug, "V-fend" (voriconazole) in tablet and injectable dosage form especially for the treatment of severe fungal infections such as invasive aspergillosis and candidasis, the adjuvant medication of hemoblast and liver implant and cancer chemothe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK